In previous study, Ding et al. [17] have found a similar result: miR-34a inhibition increases the levels of phosphorylated AMPKα separately through mediating PPARα regulation and SIRT1 pathway in hepatic steatosis mice. This evidence concerns the gene PPARA and fatty liver disease.